midodrine has been researched along with cardiovascular agents in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mansourati, J | 1 |
| Myint, PK; Ong, AC; Potter, JF; Shepstone, L | 1 |
| Cornolle, C; Dijos, M; Lafitte, S; Peyrou, J; Réant, P; Reynaud, A; Ritter, P; Roudaut, R; Touche, C | 1 |
2 review(s) available for midodrine and cardiovascular agents
| Article | Year |
|---|---|
[Orthostatic hypotension: implications for the treatment of cardiovascular diseases].
Topics: Age Factors; Aged; Antihypertensive Agents; Cardiovascular Agents; Cardiovascular Diseases; Contraindications; Drinking Water; Drug Therapy, Combination; Heart Failure; Humans; Hypotension, Orthostatic; Iatrogenic Disease; Midodrine; Patient Education as Topic; Polypharmacy; Vasoconstrictor Agents | 2012 |
A systematic review of the pharmacological management of orthostatic hypotension.
Topics: Adult; Aged; Cardiovascular Agents; Double-Blind Method; Female; Fludrocortisone; Humans; Hypotension, Orthostatic; Male; Middle Aged; Midodrine; Octreotide; Pyridostigmine Bromide; Randomized Controlled Trials as Topic; Single-Blind Method; Treatment Outcome; Young Adult | 2013 |
1 other study(ies) available for midodrine and cardiovascular agents
| Article | Year |
|---|---|
Midodrine hydrochloride and unexpected improvement in hypertrophic cardiomyopathy symptoms.
Topics: Aged; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Female; Humans; Male; Middle Aged; Midodrine; Recovery of Function; Treatment Outcome; Ventricular Function, Left | 2016 |